Literature DB >> 12713884

Reversible sclerosing cholangitis secondary to cryptosporidiosis in a renal transplant patient.

Ayman Abdo1, John Klassen, Stefan Urbanski, Earl Raber, Mark G Swain.   

Abstract

Cryptosporidium parvum is a well-known cause of chronic diarrhea. In human immunodeficiency virus (HIV)-infected patients as well as in other immunocompromised patients it has also been shown to cause sclerosing cholangitis. We report a case of reversible C. parvum-induced sclerosing cholangitis in a renal transplant patient. This 40-year-old female received a renal transplant 9 years prior to presentation. She had no history of liver disease and was doing well on tacrolimus, prednisone, and azathioprine. She developed diarrhea and was found to have C. parvum present in the stool. Shortly after, she developed clinical, biochemical, radiologic, and histologic features of SC. After accidental reduction in her immunesuppression secondary to starting her on rifampin to treat her itching, she cleared C. parvum from her stool and had a marked improvement in her diarrhea, jaundice, and general health. Her liver enzymes normalized and magnetic resonance cholangiography showed complete resolution of biliary abnormalities. To our knowledge, this is the first case of C. parvum-induced sclerosing cholangitis in a renal transplant patient and one of a few in non-HIV patients. It is also the first to document resolution of sclerosing cholangitis after eradication of C. parvum in a non-HIV patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713884     DOI: 10.1016/s0168-8278(03)00055-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

1.  Cryptosporidium parvum induces SIRT1 expression in host epithelial cells through downregulating let-7i.

Authors:  Hongguan Xie; Ningfei Lei; Ai-Yu Gong; Xian-Ming Chen; Guoku Hu
Journal:  Hum Immunol       Date:  2014-05-24       Impact factor: 2.850

2.  Cryptosporidiosis in paediatric renal transplantation.

Authors:  Flavio Bandin; Theresa Kwon; Marie-Denise Linas; Vincent Guigonis; Alexis Valentin; Sophie Cassaing; Agnes Carol; Arnaud Garnier; Veronique Baudouin; Stéphane Decramer
Journal:  Pediatr Nephrol       Date:  2009-11       Impact factor: 3.714

Review 3.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

Review 4.  Clinical significance of enteric protozoa in the immunosuppressed human population.

Authors:  D Stark; J L N Barratt; S van Hal; D Marriott; J Harkness; J T Ellis
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Genotyping of Cryptosporidium isolates from human clinical cases in Poland.

Authors:  Anna Bajer; Małgorzata Bednarska; Simone M Cacciò; Beata Wolska-Kuśnierz; Edyta Heropolitanska-Pliszka; Ewa Bernatowska; Małgorzata Wielopolska; Anna Paziewska; Renata Welc-faleciak; Edward Siński
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

Review 6.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

7.  A case of hepato-biliary infection secondary to cryptosporidium in a patient on tacrolimus.

Authors:  Sajal Gupta; Alison Johnson; Simon Meyrick; Angharad P Davies; R Chalmers
Journal:  JMM Case Rep       Date:  2018-07-20

Review 8.  Cryptosporidium infection in solid organ transplantation.

Authors:  Diana F Florescu; Uriel Sandkovsky
Journal:  World J Transplant       Date:  2016-09-24

9.  Cryptosporidiosis in a renal transplant patient treated with paromomycin.

Authors:  Abdullah Al-Amoudi; Samar Badreddine; Abdulraheem M Al-Shehri; Hassan Kanaan; Saedd M G Al-Ghamdi
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.